21st Apr 2022 15:27
JPMORGAN ELECT PLC (the 'Company') |
|
Legal Entity Identifier: 549300FIUYKKL39ILD07 |
|
THE COMPANY ANNOUNCES THE TEN LARGEST INVESTMENTS IN % OF TOTAL ASSETS As at: 31 March 2022 |
|
Managed Growth portfolio |
|
JPMorgan American Inv Trust | 14.5% |
JPM UK Equity Plus C | 8.4% |
JPMorgan Claverhouse Inv Trust | 7.9% |
JPMorgan UK Dynamic C | 6.8% |
JPMorgan US Equity All Capital C | 6.6% |
Finsbury Growth & Income | 5.0% |
Murray Income Trust | 3.7% |
JPMorgan US Value Fund | 3.4% |
JPMorgan US Select Equity C | 3.3% |
Fidelity | 3.3% |
Total | 62.9% |
Managed Income portfolio |
|
Shell | 8.2% |
AstraZeneca | 6.5% |
BP | 4.2% |
Rio Tinto | 3.8% |
GlaxoSmithKline | 3.8% |
OSB | 3.6% |
British American Tobacco | 3.2% |
Glencore | 3.1% |
Computacenter | 2.9% |
Barclays | 2.7% |
Total | 42.1% |
* Based on invested portfolio |
|
Name of contact and telephone number for queries: |
|
Paul Ainger 0044 207 742 6524 |
|
Name of authorised company official responsible for making this notification: |
|
Priyanka Vijay Anand 0044 203 493 1504 - Company Secretary |
|
Date: 21 April 2022 |
|
|
|
Related Shares:
JPE.LJPEC.LJPEI.L